Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:XENE News 5 January 2026

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

New York, January 5, 2026, 15:22 EST — Regular session Xenon Pharmaceuticals Inc (XENE) shares were down 6.5% at $41.60 in afternoon trading on Monday, about 8% off the session high. The Nasdaq-listed biotech traded between $45.21 and $41.45, with roughly 787,000 shares changing hands. The slide comes with Xenon approaching a busy stretch of investor events and trial milestones…
5 January 2026
·····

Stock Market Today

  • Foresight Group Holdings conducts share buyback purchasing 39,726 shares
    January 29, 2026, 2:16 AM EST. Foresight Group Holdings Limited announced a purchase of 39,726 ordinary shares on January 28, 2026, as part of its ongoing share buyback programme initiated in April 2025. The shares were acquired at prices ranging from 427 to 433 GBp, with a volume-weighted average price of 431.6 GBp. Post-transaction, the Group holds a total of 1,508,272 shares in treasury, which carry no voting rights. Overall, 3,159,956 ordinary shares have been repurchased under the programme. The buyback was executed through Berenberg on the London Stock Exchange. The total Ordinary Shares in issue stand at 116,347,803, with 114,839,531 carrying voting rights. This latest activity reflects Foresight's strategy to optimize its capital structure.
Go toTop